We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
How to use focus groups to evaluate your digital health product.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Information to assist with differentiating Lyme disease from other causes of rash, neurological or non-specific symptoms.
How to begin with evaluating a digital health product, including when to evaluate, budgeting and getting support.
How to use routinely collected data to evaluate your digital health product.
How to use a behaviour change techniques review to evaluate your digital health product.
Latest developments in vaccines, vaccination policies and procedures for immunisation practitioners.
Findings suggest a locally developed support package for general practice nursing teams is an effective way to improve practice-level blood pressure care and control
Guidance and tools to help collect and report data for the tobacco and alcohol commissioning for quality and innovation (CQUIN) scheme.
Check full blood counts before prescribing dimethyl fumarate and then every 6 to 12 months. Stop treatment immediately if you suspect progressive multifocal leukoencephalopathy.
Minutes of a meeting held between government, NHS England and the ABPI to review the operation of the 2019 voluntary scheme for branded medicines pricing and access.
Concerns over recent years about the use of antipsychotics to treat the behavioural and psychological symptoms of dementia (BPSD).
(All) adverse outcomes are still reported when CTG traces appear normal - this replaces alert SN 2002(23) issued August 2002. (MDA/2010/054)
Commercial pipeline providing a forward look of potential commercial activity within the Student Loans Company for the 2022 to 2023 financial year.
Information on COVID-19 including epidemiology, virology and clinical features.
A programme involving multiple interventions to improve the cardiovascular health of Bradford’s residents and reduce CVD-related deaths.
Quick reference tools for primary care providers for diagnosing and understanding culture results for urinary tract infections (UTIs).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).